-
Vale: HIV advocate Bill Paterson was ‘a mentor to many’
23 Nov 2025 00:53 GMT
… had worked for numerous HIV/AIDS organisations across his career … with HIV Australia (NAPWHA), and as Communications Manager at ViiV Healthcare.
… both People Living with HIV/AIDS (PLWHA) NSW and … of the Northern Territory AIDS and Hepatitis Council.
“ …
-
Switching to Doravirine Maintains Viral Suppression in HIV-1
18 Nov 2025 12:37 GMT
… suppression in patients with HIV-1 infection.
They … included 109 adults with HIV-1 infection (median age … aging PWH [people with HIV],” the authors wrote.
SOURCE … pharmaceutical companies including Gilead, ViiV Healthcare, Merck, Pfizer, and Moderna.
This …
-
ViiV Healthcare launches ‘Risk to Reasons’ initiative in the UK to empower women to take control of their HIV prevention choices
04 Nov 2025 16:15 GMT
… 2025 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and … deeper and broader interest in HIV and AIDS than any company has …
-
ViiV Healthcare receives NICE recommendation for HIV prevention therapy
22 Oct 2025 12:29 GMT
… by GSK and Pfizer, with Shionogi joining as a shareholder in 2024, ViiV Healthcare … focuses on developing innovative treatments for HIV and AIDS. The … long-acting formulation of Apretude is manufactured at GSK …
-
UK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment
17 Oct 2025 16:57 GMT
… GSK), Pfizer Inc (NYSE:PFE) and Shionogi Inc.
NICE has recommended ViiV Healthcare … Merck’s New HIV Treatment Works As … effective in reducing HIV risk, with 69% … HIV-negative adults and 86% of healthcare providers preferred cabotegravir over Sunlenca.
ViiV …
-
Tamar Braxton Talks About HIV
11 Nov 2025 01:58 GMT
… was presented by the HIV pharmaceutical company ViiV Healthcare. In addition to educating … about the disproportionate impact of HIV … panelist Alftan Dyson, PharmD, of ViiV. “These are the lived realities …
-
Long-Acting Regimen Shows Sustained HIV Control in Seniors
11 Nov 2025 09:39 GMT
… healthcare institutions in Spain.
They included 3146 people with HIV … TAKEAWAY:
The rates of HIV virologic suppression remained high … 21, 2025, in HIV Medicine.
LIMITATIONS:
The … receiving lecture fees from ViiV Healthcare, Janssen Pharmaceuticals, and…
-
Injectable PrEP approved in Northern Ireland following NHS milestone in monumental HIV breakthrough
10 Nov 2025 14:05 GMT
… the fight to combat HIV/AIDS.
The new long … to prevent sexually acquired HIV-1 infection.
Read next … efforts to reduce HIV incidence” – Julie Guest, ViiV Healthcare UK on the … ViiV Healthcare UK, highlighted the drug’s benefits: “Expanding the range of HIV …
-
Global Fund welcomes renewed commitment from GSK and ViiV Healthcare to expand community-led health solutions with £6 million joint pledge ahead of 8th Replenishment
20 Oct 2025 20:47 GMT
… The Global Fund to Fight AIDS, Tuberculosis and Malaria (the … GSK) and ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer … 70 million people from AIDS, TB and malaria since … and solidarity to end AIDS, TB and malaria, …
-
<![CDATA[ViiV Healthcare Announces 96-Week PASO DOBLE Results Showing Dovato as Effective as Biktarvy in Maintaining Viral Suppression ]]>
19 Oct 2025 10:38 GMT
… Biktarvy) in adults with HIV. Participants taking Dovato also … AIDS Clinical Society (EACS) Congress in Paris.
“For people living with HIV … greater than 5%.
Reference
ViiV Healthcare announces 96-week data … of HIV-1 with significantly less weight gain. ViiV …
About
© 1995-2025